Makita Y - Search Results

1

Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.

Gee P, Lung MSY, Okuzaki Y, Sasakawa N, Iguchi T, Makita Y, Hozumi H, Miura Y, Yang LF, Iwasaki M, Wang XH, Waller MA, Shirai N, Abe YO, Fujita Y, Watanabe K, Kagita A, Iwabuchi KA, Yasuda M, Xu H, Noda T, Komano J, Sakurai H, Inukai N, Hotta A. Gee P, et al. Among authors: makita y. Nat Commun. 2020 Mar 13;11(1):1334. doi: 10.1038/s41467-020-14957-y. Nat Commun. 2020. PMID: 32170079 Free PMC article.

2

[Advances in genome editing technologies for treating muscular dystrophy.].

Makita Y, Hozumi H, Hotta A. Makita Y, et al. Clin Calcium. 2017;27(3):391-399. Clin Calcium. 2017. PMID: 28232654 Japanese.

3

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice.

Kenjo E, Hozumi H, Makita Y, Iwabuchi KA, Fujimoto N, Matsumoto S, Kimura M, Amano Y, Ifuku M, Naoe Y, Inukai N, Hotta A. Kenjo E, et al. Among authors: makita y. Nat Commun. 2021 Dec 8;12(1):7101. doi: 10.1038/s41467-021-26714-w. Nat Commun. 2021. PMID: 34880218 Free PMC article.

4

Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles.

Sugo T, Terada M, Oikawa T, Miyata K, Nishimura S, Kenjo E, Ogasawara-Shimizu M, Makita Y, Imaichi S, Murata S, Otake K, Kikuchi K, Teratani M, Masuda Y, Kamei T, Takagahara S, Ikeda S, Ohtaki T, Matsumoto H. Sugo T, et al. Among authors: makita y. J Control Release. 2016 Sep 10;237:1-13. doi: 10.1016/j.jconrel.2016.06.036. Epub 2016 Jun 29. J Control Release. 2016. PMID: 27369865

5

Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma.

Makita Y, Murata S, Katou Y, Kikuchi K, Uejima H, Teratani M, Hoashi Y, Kenjo E, Matsumoto S, Nogami M, Otake K, Kawamata Y. Makita Y, et al. Biochem Biophys Res Commun. 2017 Nov 4;493(1):800-806. doi: 10.1016/j.bbrc.2017.08.088. Epub 2017 Aug 23. Biochem Biophys Res Commun. 2017. PMID: 28843857 Free article.

6

Intranasal oxytocin suppresses seizure-like behaviors in a mouse model of NGLY1 deficiency.

Makita Y, Asahina M, Fujinawa R, Yukitake H, Suzuki T. Makita Y, et al. Commun Biol. 2024 Apr 22;7(1):460. doi: 10.1038/s42003-024-06131-7. Commun Biol. 2024. PMID: 38649481 Free PMC article.

7

Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.

Muraki Y, Makita Y, Yamasaki M, Amano Y, Matsuo T. Muraki Y, et al. Among authors: makita y. Biochem Biophys Res Commun. 2017 May 6;486(3):632-638. doi: 10.1016/j.bbrc.2017.03.072. Epub 2017 Mar 18. Biochem Biophys Res Commun. 2017. PMID: 28322783

8

Antitumor activity of kinetochore-associated protein 2 siRNA against lung cancer patient-derived tumor xenografts.

Makita Y, Teratani M, Murata S, Hoashi Y, Matsumoto S, Kawamata Y. Makita Y, et al. Oncol Lett. 2018 Apr;15(4):4676-4682. doi: 10.3892/ol.2018.7890. Epub 2018 Jan 29. Oncol Lett. 2018. PMID: 29541240 Free PMC article.

9

Peroxidase activity in human red cell: a biological model for excited state molecules generation.

Durán N, Makita Y, Innocentini LH. Durán N, et al. Among authors: makita y. Biochem Biophys Res Commun. 1979 May 28;88(2):642-8. doi: 10.1016/0006-291x(79)92096-5. Biochem Biophys Res Commun. 1979. PMID: 465061 No abstract available.

10

Photobiochemistry in the dark: photohemolysis of red cells sensitized by chlorpromazine-bioenergized triplet acetone system.

Makita Y, Durán N. Makita Y, et al. Biochem Biophys Res Commun. 1979 Nov 28;91(2):427-33. doi: 10.1016/0006-291x(79)91539-0. Biochem Biophys Res Commun. 1979. PMID: 518642 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page